08.18.20

DivcoWest Welcomes Bristol Myers Squibb to Cambridge Crossing

Cambridge, MA, (August 18, 2020) – DivcoWest announced today that it has signed a 360,000 square-foot lease with Bristol Myers Squibb (NYSE:BMY) at 250 Water Street in Cambridge Crossing (CX), the new and connected neighborhood at the intersection of Cambridge, Somerville, and Boston. The new building is currently under construction and is expected to be complete in late 2022. Bristol Myers Squibb plans to combine its Cambridge presence at the state-of-the-art laboratory and office building at 250 Water Street by the end of the first half of 2023. Dedicated to helping patients prevail over serious diseases, the biopharmaceutical company will join Philips North America, Sanofi, and Cerevel Therapeutics in the vibrant CX community.